scispace - formally typeset
R

Robert W. Buchanan

Researcher at University of Maryland, Baltimore

Publications -  331
Citations -  25562

Robert W. Buchanan is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Schizophrenia & Schizophrenia (object-oriented programming). The author has an hindex of 88, co-authored 309 publications receiving 23796 citations. Previous affiliations of Robert W. Buchanan include University of Maryland, College Park & Veterans Health Administration.

Papers
More filters
Journal ArticleDOI

The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2003

TL;DR: Evidence points to the value of treatment approaches combining medications with psychosocial treatments, including psychological interventions, family interventions, supported employment, assertive community treatment, and skills training.
Journal ArticleDOI

The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements

TL;DR: An extensive literature review was conducted to determine whether the current psychopharmacological treatment recommendations required revision and whether there was sufficient evidence to warrant new treatment recommendations for prespecified outcomes of interest.
Journal ArticleDOI

The Schedule for the Deficit syndrome: an instrument for research in schizophrenia.

TL;DR: The Schedule for the Deficit Syndrome is an instrument for categorizing schizophrenic patients into those with and those without the deficit syndrome, and raters using the SDS demonstrated good interrater reliability for this categorization.
Journal ArticleDOI

A separate disease within the syndrome of schizophrenia.

TL;DR: It is proposed that deficit psychopathology (ie, enduring, idiopathic negative symptoms) defines a group of patients with a disease different from schizophrenia without deficit features, as the deficit and nondeficit groups differ in their signs and symptoms, course, biological correlates, treatment response, and etiologic factors.
Journal ArticleDOI

The neurological evaluation scale (NES): A structured instrument for the assessment of neurological signs in schizophrenia

TL;DR: Preliminary validity data demonstrate the ability of theNES battery to discriminate patients with schizophrenia from nonpsychiatric controls and the interrater reliability for total score, functional areas of interest, and individual items.